Mohammed Lamorde

4.4k total citations
156 papers, 2.4k citations indexed

About

Mohammed Lamorde is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Mohammed Lamorde has authored 156 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Infectious Diseases, 36 papers in Public Health, Environmental and Occupational Health and 30 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Mohammed Lamorde's work include HIV/AIDS drug development and treatment (58 papers), HIV/AIDS Research and Interventions (52 papers) and HIV Research and Treatment (23 papers). Mohammed Lamorde is often cited by papers focused on HIV/AIDS drug development and treatment (58 papers), HIV/AIDS Research and Interventions (52 papers) and HIV Research and Treatment (23 papers). Mohammed Lamorde collaborates with scholars based in Uganda, United Kingdom and United States. Mohammed Lamorde's co-authors include Andreas Kuznik, Pauline Byakika‐Kibwika, Barbara Castelnuovo, Yukari C. Manabe, Andrew Kambugu, Saye Khoo, Abdulrazaq G. Habib, Catriona Waitt, David Back and Kimberly K. Scarsi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Nature Reviews Microbiology.

In The Last Decade

Mohammed Lamorde

147 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mohammed Lamorde Uganda	27	1.1k	516	458	433	315	156	2.4k
Michaël Boele van Hensbroek Netherlands	32	700 0.6×	1.3k 2.5×	281 0.6×	422 1.0×	233 0.7×	121	3.0k
Aditya H. Gaur United States	32	1.1k 1.0×	377 0.7×	1.1k 2.4×	383 0.9×	338 1.1×	111	3.4k
Lubbe Wiesner South Africa	32	2.0k 1.8×	561 1.1×	1.1k 2.3×	451 1.0×	354 1.1×	246	3.6k
Michiel A. van Agtmael Netherlands	33	897 0.8×	1.0k 2.0×	902 2.0×	208 0.5×	399 1.3×	143	3.9k
Olivier Bouchaud France	28	955 0.8×	1.0k 2.0×	517 1.1×	107 0.2×	139 0.4×	183	2.6k
Tamara D. Clark United States	36	1.7k 1.5×	1.3k 2.4×	920 2.0×	677 1.6×	454 1.4×	104	3.5k
Dorothy Bray United Kingdom	21	1.3k 1.1×	551 1.1×	551 1.2×	129 0.3×	638 2.0×	30	2.8k
Jane Achan Uganda	31	909 0.8×	1.6k 3.0×	326 0.7×	481 1.1×	439 1.4×	96	3.1k
David Ofori‐Adjei Ghana	35	658 0.6×	695 1.3×	1.0k 2.3×	558 1.3×	145 0.5×	110	3.9k
Said Aboud Tanzania	34	1.2k 1.0×	457 0.9×	994 2.2×	626 1.4×	286 0.9×	180	3.6k

Countries citing papers authored by Mohammed Lamorde

Since Specialization

Citations

This map shows the geographic impact of Mohammed Lamorde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammed Lamorde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammed Lamorde more than expected).

Fields of papers citing papers by Mohammed Lamorde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammed Lamorde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammed Lamorde. The network helps show where Mohammed Lamorde may publish in the future.

Co-authorship network of co-authors of Mohammed Lamorde

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammed Lamorde. A scholar is included among the top collaborators of Mohammed Lamorde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammed Lamorde. Mohammed Lamorde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nicolò, Amedeo De, Alessandra Manca, Jessica Cusato, et al.. (2025). A Novel HPLC-MS/MS Method for the Intracellular Quantification of the Active Triphosphate Metabolite of Remdesivir: GS-443902. Journal of Xenobiotics. 15(4). 107–107.

Nicolò, Amedeo De, Henry Mugerwa, Mohammed Lamorde, et al.. (2025). Intracellular Penetration of Atazanavir, Ritonavir and Dolutegravir With Concomitant Rifampicin: A Dose Escalation Study. Clinical Pharmacology & Therapeutics. 117(5). 1393–1402. 1 indexed citations

Kandathil, Abraham J., Paul W. Blair, Jennifer Lu, et al.. (2024). Metagenomic next generation sequencing of plasma RNA for diagnosis of unexplained, acute febrile illness in Uganda. PLoS neglected tropical diseases. 18(9). e0012451–e0012451. 2 indexed citations

Mayito, Jonathan, et al.. (2024). Establishing Antimicrobial Resistance Surveillance in the Water and Environment Sector in a Resource-Limited Setting: Methodical Qualitative and Quantitative Description of Uganda’s Experience From 2021 to 2023. 2. e50588–e50588. 5 indexed citations

Cirrincione, Lauren R., Catherine A. Chappell, Pauline Byakika‐Kibwika, et al.. (2023). Effect of double-dose levonorgestrel subdermal implant in women taking efavirenz-based antiretroviral therapy: The DoubLNG pharmacokinetic study. Contraception. 122. 109975–109975. 5 indexed citations

Musaazi, Joseph, Allan Buzibye, Rob E. Aarnoutse, et al.. (2023). Dolutegravir pharmacokinetics in Ugandan patients with TB and HIV receiving standard- versus high-dose rifampicin. Antimicrobial Agents and Chemotherapy. 67(11). e0043023–e0043023. 4 indexed citations

Mugerwa, Henry, Marco Siccardi, Maiara Camotti Montanha, et al.. (2023). Pharmacokinetics and Safety of Twice-daily Ritonavir-boosted Atazanavir With Rifampicin. Clinical Infectious Diseases. 78(5). 1246–1255. 6 indexed citations

Laker, Eva, Fiona V Cresswell, Mohammed Lamorde, et al.. (2022). High willingness to use injectable antiretroviral therapy among women who have been lost to follow‐up from HIV programmes: A nested cross‐sectional study. HIV Medicine. 23(4). 319–323. 4 indexed citations

Twimukye, Adelline, Thokozile R. Malaba, Landon Myer, et al.. (2022). “It’s only fatness, it doesn’t kill”: a qualitative study on perceptions of weight gain from use of dolutegravir-based regimens in women living with HIV in Uganda. BMC Women s Health. 22(1). 246–246. 12 indexed citations

10.

Chappell, Catherine A., Pauline Byakika‐Kibwika, Julian Kaboggoza, et al.. (2022). Pharmacokinetics of levonorgestrel and etonogestrel contraceptive implants over 48 weeks with rilpivirine- or darunavir-based antiretroviral therapy. Journal of Antimicrobial Chemotherapy. 77(11). 3144–3152. 6 indexed citations

11.

Walimbwa, Stephen, Goonaseelan Pillai, Saye Khoo, et al.. (2021). Dolutegravir pharmacokinetics during co-administration with either artemether/lumefantrine or artesunate/amodiaquine. Journal of Antimicrobial Chemotherapy. 76(5). 1269–1272. 5 indexed citations

12.

Yang, Fan, Kenneth Katumba, Bram Roudijk, et al.. (2021). Developing the EQ-5D-5L Value Set for Uganda Using the ‘Lite’ Protocol. PharmacoEconomics. 40(3). 309–321. 19 indexed citations

13.

Lamorde, Mohammed, et al.. (2021). Improving compliance to workplace prevention and control (IPC) measures during the COVID-19 pandemic in a non-healthcare setting. Antimicrobial Resistance and Infection Control. 10. 1 indexed citations

14.

Twimukye, Adelline, Agnes Bwanika Naggirinya, Rosalind Parkes‐Ratanshi, et al.. (2021). Acceptability of a Mobile Phone Support Tool (Call for Life Uganda) for Promoting Adherence to Antiretroviral Therapy Among Young Adults in a Randomized Controlled Trial: Exploratory Qualitative Study. JMIR mhealth and uhealth. 9(6). e17418–e17418. 22 indexed citations

15.

Musinguzi, Patrick, Meklit Workneh, Richard Walwema, et al.. (2020). Implementation of a standardised and quality-assured enhanced gonococcal antimicrobial surveillance programme in accordance with WHO protocols in Kampala, Uganda. Sexually Transmitted Infections. 97(4). 312–316. 14 indexed citations

16.

Workneh, Meklit, Matthew M. Hamill, Olive Mbabazi, et al.. (2020). Antimicrobial Resistance of Neisseria Gonorrhoeae in a Newly Implemented Surveillance Program in Uganda: Surveillance Report. JMIR Public Health and Surveillance. 6(2). e17009–e17009. 16 indexed citations

17.

Sekaggya‐Wiltshire, Christine, Maxwell Chirehwa, Joseph Musaazi, et al.. (2019). Low Antituberculosis Drug Concentrations in HIV-Tuberculosis-Coinfected Adults with Low Body Weight: Is It Time To Update Dosing Guidelines?. Antimicrobial Agents and Chemotherapy. 63(6). 41 indexed citations

18.

Lamorde, Mohammed, Pauline Byakika‐Kibwika, & Concepta Merry. (2012). Pharmacokinetic interactions between antiretroviral drugs and herbal medicines. British Journal of Hospital Medicine. 73(3). 132–136. 2 indexed citations

19.

Babigumira, Joseph B., Barbara Castelnuovo, Andy Stergachis, et al.. (2011). Cost Effectiveness of a Pharmacy-Only Refill Program in a Large Urban HIV/AIDS Clinic in Uganda. PLoS ONE. 6(3). e18193–e18193. 41 indexed citations

20.

Lamorde, Mohammed, Pauline Byakika‐Kibwika, John P. Flaherty, et al.. (2010). Suboptimal Nevirapine Steady-State Pharmacokinetics During Intrapartum Compared With Postpartum in HIV-1-Seropositive Ugandan Women. JAIDS Journal of Acquired Immune Deficiency Syndromes. 55(3). 345–350. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact